Literature DB >> 6459640

The lipids of red cell membranes. Compositional, structural and functional aspects.

B Roelofsen, G van Meer, J A Op den Kamp.   

Abstract

The structural matrix of the erythrocyte membrane is provided by a lipid bilayer containing more than one hundred different molecular species of lipid. The phospho- and glycolipids are distributed over the two halves of the bilayer in a highly asymmetric fashion; the outer monolayer consisting of all the glycolipids and the greater part of the two choline-containing phospholipids, whereas the amino-containing phospholipids dominate the inner monolayer. Functional implications of this arrangement are still poorly understood, but some of them may be found in blood coagulation and lipid-requiring membrane-bound enzymes. The bilayer exhibits a high degree of stability as is illustrated by 31P-NMR studies of membranes treated with phospholipases. However, selective modification of the molecular species of lecithin in the outer monolayer may lead to such destabilizations that the structural integrity of the membrane is lost and the cells haemolyse.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6459640     DOI: 10.3109/00365518109097442

Source DB:  PubMed          Journal:  Scand J Clin Lab Invest Suppl        ISSN: 0085-591X


  3 in total

1.  Biochemical studies on the isolation and characterization of human spleen haemosiderin.

Authors:  M P Weir; J F Gibson; T J Peters
Journal:  Biochem J       Date:  1984-10-01       Impact factor: 3.857

2.  Effects of dietary supplementation of saturated fatty acids and of n-6 or n-3 polyunsaturated fatty acids on plasma and red blood cell membrane phospholipids and deformability in weanling guinea pigs.

Authors:  J M Pöschl; K Paul; M Leichsenring; S R Han; M Pfisterer; H J Bremer; O Linderkamp
Journal:  Lipids       Date:  1999-05       Impact factor: 1.880

Review 3.  The immune functions of phosphatidylserine in membranes of dying cells and microvesicles.

Authors:  Benjamin Frey; Udo S Gaipl
Journal:  Semin Immunopathol       Date:  2010-10-13       Impact factor: 11.759

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.